Dr. David Ron's work is focused on the cellular response to proteotoxic stress, and the impact of malfolded proteins on diseases such as type 2 diabetes. It is anticipated that identification of components of the cellular response to proteotoxic stress will provide the scaffold upon which to build pharmacological tools that will enable the manipulation of these responses to favorable ends.